Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,862,621
-
Share change
-
-4,268,126
-
Total reported value
-
$1,792,987,138
-
Put/Call ratio
-
29%
-
Price per share
-
$113.10
-
Number of holders
-
115
-
Value change
-
-$413,607,662
-
Number of buys
-
52
-
Number of sells
-
79
Institutional Holders of CHINA BIOLOGIC PRODS INC - COM (CBPO) as of Q2 2017
As of 30 Jun 2017,
CHINA BIOLOGIC PRODS INC - COM (CBPO) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,862,621 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., BAILLIE GIFFORD & CO, Invesco Ltd., FIL Ltd, Hillhouse Capital Management, Ltd., HERMES INVESTMENT MANAGEMENT LTD, MACQUARIE GROUP LTD, Bank of New York Mellon Corp, and SCHRODER INVESTMENT MANAGEMENT GROUP.
This page lists
115
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.